OPC-262

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for OPC-262, covering 2014-01-08 to 2017-03-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes [Phase 2]